Vitamin D and Sleep Disorders in Pregnancy
Do Low Vitramin D Levels Increase the Frequency of Sleep Disorders and Anxiety in the 2nd and 3rd Trimester?
1 other identifier
observational
225
1 country
1
Brief Summary
Lack of sleep and poor sleep quality in pregnant women are associated with maternal depression and cognitive-sensual irregularities. These irregularities were reported worsening women's life quality and even increasing suicide ideation. It is also associated with obstetrical complications such as fetal growth deficiency, preterm birth, prolonged labor, preeclampsia and increased abdominal delivery frequency.Vitamin D also may affect the sleep indirectly through the cases with nonspecific pains. It was reported that vitamin D levels are correlated with sleep disorders such as obstructive sleep apnea and restless legs syndrome. The primary purpose of this study is to examine sleep disorders and vitamin D levels in pregnant women, and also, secondarily, vitamin D - anxiety and sleep disorders - anxiety relations were assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2019
CompletedFirst Submitted
Initial submission to the registry
April 17, 2021
CompletedFirst Posted
Study publicly available on registry
June 8, 2021
CompletedAugust 25, 2021
April 1, 2018
1.3 years
April 17, 2021
August 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Health Initiative Sleeplessness Scale (WHISS)
Women's Health Initiative Sleeplessness Scale (WHISS) was used to assess the sleep status of pregnant women. In this scale consisting of five questions, first four questions focus on the period of time when sleeplessness started, status of not being able to continue the sleep and waking up early in the morning, while the last one focusses to determine the sleep quality. Scores of the scale range between 0 - 20. A score equal and above 10 means a sleeplessness problem. An increase in score means intensifying the sleeplessness symptoms.
Through study completion, an average of 1 year
State Anxiety Scale (SAS)
In anxiety screening of pregnant women, State Anxiety Scale (SAS) was used. Scores of the scale including twenty questions range between min. 20 and max. 80. Higher scores mean higher anxiety.
Through study completion, an average of 1 year
Study Arms (1)
Pregnant women between 18-45 years old, being in second and third trimester of a singleton pregnancy
Interventions
Women's Health Initiative Sleeplessness Scale (WHISS) and State Anxiety Scale (SAS), were applied.
Eligibility Criteria
225 pregnant women who are in second or third trimester of pregnancy
You may qualify if:
- singletone pregnant women
- second and third trimester pregnant women
You may not qualify if:
- psychiatric disorder
- sleep disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fatma Ketenci Gencer
Istanbul, 34255, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
April 17, 2021
First Posted
June 8, 2021
Study Start
August 20, 2017
Primary Completion
December 25, 2018
Study Completion
March 15, 2019
Last Updated
August 25, 2021
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share